WallStSmart

Fresenius Medical Care Corporation (FMS)vsP3 Health Partners Inc (PIII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 1258% more annual revenue ($19.63B vs $1.44B). FMS leads profitability with a 5.0% profit margin vs -9.1%. FMS earns a higher WallStSmart Score of 62/100 (C+).

FMS

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 5.0Value: 10.0Quality: 7.0
Piotroski: 6/9Altman Z: 1.82

PIII

Avoid

32

out of 100

Grade: F

Growth: 3.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FMSUndervalued (+73.4%)

Margin of Safety

+73.4%

Fair Value

$90.32

Current Price

$22.03

$68.29 discount

UndervaluedFair: $90.32Overvalued

Intrinsic value data unavailable for PIII.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
11.2x10/10

Attractively priced relative to earnings

Price/BookValuation
0.4x10/10

Reasonable price relative to book value

PEG RatioValuation
0.738/10

Growing faster than its price suggests

PIII0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

FMS4 concerns · Avg: 3.5/10
EPS GrowthGrowth
4.2%4/10

4.2% earnings growth

Altman Z-ScoreHealth
1.824/10

Grey zone — moderate risk

Return on EquityProfitability
7.9%3/10

ROE of 7.9% — below average capital efficiency

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

PIII4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$615.53M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-2.0%2/10

ROE of -2.0% — below average capital efficiency

Revenue GrowthGrowth
-4.7%2/10

Revenue declined 4.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bull Case : PIII

PIII has a balanced fundamental profile.

Bear Case : FMS

The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.

Bear Case : PIII

The primary concerns for PIII are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

FMS profiles as a value stock while PIII is a turnaround play — different risk/reward profiles.

FMS carries more volatility with a beta of 0.94 — expect wider price swings.

FMS is growing revenue faster at -0.3% — sustainability is the question.

FMS generates stronger free cash flow (564M), providing more financial flexibility.

Bottom Line

FMS scores higher overall (62/100 vs 32/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

P3 Health Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

P3 Health Partners Inc (PIII) is an innovative healthcare organization committed to enhancing care quality and reducing costs through a robust data-driven strategy. By leveraging advanced analytics and telehealth technologies, P3 prioritizes personalized care for underserved populations while fostering an extensive network of primary care providers and specialists. As a leader in value-based care models, the company strategically collaborates with community partners to meet the rising demand for efficient healthcare solutions. With a steadfast dedication to deliver high-quality and cost-effective care, PIII is well-positioned to navigate and thrive in the evolving healthcare landscape.

Want to dig deeper into these stocks?